Research papers of the week – April 11, 2022

Aminopropyltriethoxysilane (APTES)-Modified Nanohydroxyapatite (nHAp) Incorporated with Iron Oxide (IO) Nanoparticles Promotes Early Osteogenesis, Reduces Inflammation and Inhibits Osteoclast Activity

Krzysztof Marycz, Katarzyna Kornicka-Garbowska, Adrian Patej, Paulina Sobierajska, Andrzej Kotela, Eliza Turlej, Martyna Kępska, Alina Bienko, Rafał J. Wiglusz
Materials

Ministerial score = 140.0
Journal Impact Factor (2020) = 3.623 (Q1)

materials-1.jpgDue to its increased prevalence, osteoporosis (OP) represents a great challenge to health care systems and brings an economic burden. To overcome these issues, treatment plans that suit the need of patients should be developed. One of the approaches focuses on the fabrication of personalized biomaterials, which can restore the balance and homeostasis of disease-affected bone. In the presented study, we fabricated nanometer crystalline hydroxyapatite (nHAp) and iron oxide (IO) nanoparticles stabilized with APTES and investigated whether they can modulate bone cell metabolism and be useful in the fabrication of personalized materials for OP patients. Using a wide range of molecular techniques, we have shown that obtained nHAp@APTES promotes viability and RUNX-2 expression in osteoblasts, as well as reducing activity of critical proinflammatory cytokines while inhibiting osteoclast activity. Materials with APTES modified with nHAp incorporated with IO nanoparticles can be applied to support the healing of osteoporotic bone fractures as they enhance metabolic activity of osteoblasts and diminish osteoclasts’ metabolism and inflammation.

DOI:10.3390/ma15062095

READ THE PAPER UPWr Base


magnacarta-logo.jpg eua-logo.png hr_logo.png logo.png eugreen_logo_simple.jpg iroica-logo.png bic_logo.png